Delayed antibiotics for respiratory infections (Review) by Spurling, Geoffrey K. P. et al.
Delayed antibiotics for respiratory infections (Review)
Spurling GKP, Del Mar CB, Dooley L, Foxlee R
This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library
2007, Issue 3
http://www.thecochranelibrary.com
Delayed antibiotics for respiratory infections (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
10DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
14CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 Sore throat - pain; Delayed versus Immediate Antibiotics, Outcome 1 Pain on Day 3. . 26
Analysis 1.2. Comparison 1 Sore throat - pain; Delayed versus Immediate Antibiotics, Outcome 2 Pain severity on Day 3. 27
Analysis 2.1. Comparison 2 Sore throat - malaise; Delayed versus Immediate Antibiotics, Outcome 1 Malaise on Day 3. 27
Analysis 2.2. Comparison 2 Sore throat - malaise; Delayed versus Immediate Antibiotics, Outcome 2 Malaise severity. 28
Analysis 3.1. Comparison 3 Sore throat - fever; Delayed versus Immediate Antibiotics, Outcome 1 Fever severity on Day
3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Analysis 3.2. Comparison 3 Sore throat - fever; Delayed versus Immediate Antibiotics, Outcome 2 Fever severity on Day
1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Analysis 4.1. Comparison 4 AOM - pain; Delayed versus Immediate Antibiotics, Outcome 1 Pain on Day 3. . . . 29
Analysis 4.2. Comparison 4 AOM - pain; Delayed versus Immediate Antibiotics, Outcome 2 Pain on Days 4 to 6. . 30
Analysis 4.3. Comparison 4 AOM - pain; Delayed versus Immediate Antibiotics, Outcome 3 Pain on Day 7. . . . 30
Analysis 4.4. Comparison 4 AOM - pain; Delayed versus Immediate Antibiotics, Outcome 4 Pain severity on Day 3. 31
Analysis 4.5. Comparison 4 AOM - pain; Delayed versus Immediate Antibiotics, Outcome 5 Pain severity on Day 7. 31
Analysis 5.1. Comparison 5 AOM - malaise; Delayed versus Immediate Antibiotics, Outcome 1 Malaise on Day 3. . 32
Analysis 5.2. Comparison 5 AOM - malaise; Delayed versus Immediate Antibiotics, Outcome 2 Malaise severity on Day
3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Analysis 5.3. Comparison 5 AOM - malaise; Delayed versus Immediate Antibiotics, Outcome 3 Malaise severity on Day
7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Analysis 6.1. Comparison 6 Supplementary medicine consumption; Delayed versus Immediate Antibiotics, Outcome 1
Spoons of paracetamol/day. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Analysis 6.2. Comparison 6 Supplementary medicine consumption; Delayed versus Immediate Antibiotics, Outcome 2
Use of paracetamol and ibuprofen. . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Analysis 7.1. Comparison 7 AOM - fever; Delayed versus Immediate Antibiotics, Outcome 1 Fever Days 4 to 6. . . 34
Analysis 8.1. Comparison 8 AOM - pain; Delayed versus No Antibiotics, Outcome 1 Otitis media pain on Day 3 delayed
versus none. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
Analysis 9.1. Comparison 9 AOM - fever; Delayed versus No Antibiotics, Outcome 1 Otitis media number of patients with
fever on Day 3 delayed versus none. . . . . . . . . . . . . . . . . . . . . . . . . . . 35
Analysis 10.1. Comparison 10 Common cold - pain; Delayed versus Immediate Antibiotics, Outcome 1 Pain on Day 3. 36
Analysis 10.2. Comparison 10 Common cold - pain; Delayed versus Immediate Antibiotics, Outcome 2 Pain on Day 7. 36
Analysis 11.1. Comparison 11 Common cold - fever; Delayed versus Immediate Antibiotics, Outcome 1 Fever on Day 3. 37
Analysis 11.2. Comparison 11 Common cold - fever; Delayed versus Immediate Antibiotics, Outcome 2 Fever on Day 7. 37
Analysis 11.3. Comparison 11 Common cold - fever; Delayed versus Immediate Antibiotics, Outcome 3 Fever severity on
Day 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Analysis 11.4. Comparison 11 Common cold - fever; Delayed versus Immediate Antibiotics, Outcome 4 Fever severity on
Day 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
iDelayed antibiotics for respiratory infections (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 11.5. Comparison 11 Common cold - fever; Delayed versus Immediate Antibiotics, Outcome 5 Fever severity on
Day 7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
Analysis 12.1. Comparison 12 Common cold - cough; Delayed versus Immediate Antibiotics, Outcome 1 Cough on Day
3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
Analysis 12.2. Comparison 12 Common cold - cough; Delayed versus Immediate Antibiotics, Outcome 2 Cough on Day
7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Analysis 13.1. Comparison 13 Antibiotic use; Delayed versus Immediate Antibiotics, Outcome 1 Antibiotic use: immediate
versus delayed antibiotics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Analysis 14.1. Comparison 14 Antibiotic use; Delayed versus No Antibiotics, Outcome 1 Antibiotic use: delayed versus no
antibiotics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Analysis 15.1. Comparison 15 Patient satisfaction; Delayed versus Immediate Antibiotics, Outcome 1 Patient satisfaction:
Delayed versus Immediate Antibiotics. . . . . . . . . . . . . . . . . . . . . . . . . . 41
Analysis 16.1. Comparison 16 Patient satisfaction; Delayed versus No Antibiotics, Outcome 1 Patient satisfaction: delayed
antibiotics versus no antibiotics. . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Analysis 17.1. Comparison 17 Adverse events: Delayed versus Immediate Antibiotics, Outcome 1 Vomiting. . . . 43
Analysis 17.2. Comparison 17 Adverse events: Delayed versus Immediate Antibiotics, Outcome 2 Diarrhoea. . . . 43
Analysis 17.3. Comparison 17 Adverse events: Delayed versus Immediate Antibiotics, Outcome 3 Rash. . . . . . 44
Analysis 17.4. Comparison 17 Adverse events: Delayed versus Immediate Antibiotics, Outcome 4 Stomach ache. . . 44
Analysis 18.1. Comparison 18 Adverse events: Delayed versus No Antibiotics, Outcome 1 Vomiting. . . . . . . 45
Analysis 18.2. Comparison 18 Adverse events: Delayed versus No Antibiotics, Outcome 2 Diarrhoea. . . . . . . 45
Analysis 18.3. Comparison 18 Adverse events: Delayed versus No Antibiotics, Outcome 3 Rash. . . . . . . . 46
Analysis 18.4. Comparison 18 Adverse events: Delayed versus No Antibiotics, Outcome 4 Stomach ache. . . . . 46
Analysis 19.1. Comparison 19 Re-consultation rate; Delayed versus Immediate Antibiotics, Outcome 1 Reconsultation
rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
47ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
51APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
53FEEDBACK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
54WHAT’S NEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
54HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
55CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
55DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
55SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
56INDEX TERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iiDelayed antibiotics for respiratory infections (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Delayed antibiotics for respiratory infections
Geoffrey KP Spurling1, Chris B Del Mar2, Liz Dooley2, Ruth Foxlee3
1Discipline of General Practice, Level 2, Edith Cavell Building, University of Queensland, Royal Brisbane Hospital, Brisbane, Australia.
2Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia. 3Department of Health Sciences, University of
York, York, UK
Contact address: Geoffrey KP Spurling, Discipline of General Practice, Level 2, Edith Cavell Building, University of Queensland, Royal
Brisbane Hospital, Brisbane, Queensland, 4029, Australia. geoffspurling@optusnet.com.au. g.spurling@uq.edu.au.
Editorial group: Cochrane Acute Respiratory Infections Group.
Publication status and date: Edited (no change to conclusions), published in Issue 1, 2011.
Review content assessed as up-to-date: 26 March 2009.
Citation: Spurling GKP, Del Mar CB, Dooley L, Foxlee R. Delayed antibiotics for respiratory infections. Cochrane Database of
Systematic Reviews 2007, Issue 3. Art. No.: CD004417. DOI: 10.1002/14651858.CD004417.pub3.
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Concerns exist regarding antibiotic prescribing for acute respiratory tract infections (ARTIs) owing to adverse reactions, cost and
antibacterial resistance. One strategy to reduce antibiotic prescribing is to provide prescriptions, but to advise delay in the hope
symptoms will resolve first.
Objectives
To evaluate clinical outcomes, adverse effects, antibiotic use and patient satisfaction associated with delayed antibiotic prescribing
compared to immediate prescribing or no antibiotics for ARTIs.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2009, issue 1), which contains
the Acute Respiratory Infections Group’s Specialised Register; MEDLINE (January 1966 to March Week 3 2009), EMBASE (1990 to
2009 Week 12), CINAHL (1982 to March Week 4 2009); Current Contents (1998 to December 2007) and Science Citation Index
(2007 to March 2009).
Selection criteria
Randomised controlled trials (RCTs) involving participants of all ages defined as having an ARTI, where delayed antibiotics were
compared to antibiotics used immediately or no antibiotics.
Data collection and analysis
Data were collected and analysed by three review authors.
Main results
Heterogeneity of the 10 included studies and their results generally precludedmeta-analysis with patient satisfaction being an exception.
There was no difference between delayed, immediate and no prescribed antibiotics for the clinical outcomes cough and common cold.
In patients with acute otitis media (AOM) and sore throat immediate antibiotics were more effective than delayed for fever, pain and
malaise in some studies. There were only minor differences in adverse effects with no significant difference in complication rates.
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Delayed antibiotics resulted in a significant reduction in antibiotics compared to immediate antibiotics. A strategy of no antibiotics
resulted in least antibiotic use.
Patient satisfaction favoured immediate antibiotics over delayed (OR 0.52; 95% CI 0.35 to 0.76). Delayed and no antibiotics had similar
satisfaction rates with both strategies achieving over 80% satisfaction (OR 1.44; 95% CI 0.99 to 2.10).
There was no difference in re-consultation rates for immediate and delayed groups.
Authors’ conclusions
Most clinical outcomes show no difference between strategies. Delay slightly reduces patient satisfaction compared to immediate
antibiotics (87% versus 92%), but not compared to none (87% versus 83%). In patients with respiratory infections where clinicians
feel it is safe not to prescribe antibiotics immediately, no antibiotics with advice to return if symptoms do not resolve is likely to result
in the least antibiotic use, while maintaining similar patient satisfaction and clinical outcomes to delayed antibiotics.
P L A I N L A N G U A G E S U M M A R Y
Delayed antibiotics for symptoms and complications of acute respiratory tract infections
Previous reviews indicate that antibiotics have, at best, only modest benefit for acute respiratory tract infections (ARTIs). These benefits
need to be balanced against adverse effects, costs, and the risk of bacteria becoming resistant to antibiotics. One way for doctors to
reduce the use of antibiotics is to prescribe delayed, (meaning providing the prescription, but advising the patient/carer to delay their
use in the hope that symptoms resolve first). Delayed prescribing resulted in 32% of patients using antibiotics compared to 93% of
patients in the immediate prescription group. However, not prescribing antibiotics at all results in the least antibiotic prescribing (14%
of patients used antibiotics).
While this review found 10 studies looking at prescribing strategies for respiratory infections, it was generally not possible to combine
results from different studies because of incomplete information from some studies and the different types of patients in each study.
There were only three trials comparing the strategies of delayed and no antibiotics.
For most symptoms like fever, pain and malaise, there was no difference between immediate, delayed and no antibiotics. The only
differences were small and favoured immediate antibiotics for relieving pain and fever for sore throat and pain and malaise for middle
ear infections. There was little difference in adverse effects of antibiotics for the three prescribing strategies and no significant difference
in complication rates.
Patient satisfaction was slightly reduced in the delayed antibiotic group (87% satisfied) compared to the immediate antibiotic group
(92% satisfied). Satisfaction rates were similar between delayed and no antibiotic groups (83% satisfied).
When doctors feel it is safe not to prescribe antibiotics immediately, prescribing none with advice to return if symptoms do not resolve
rather than delaying them will result in lower subsequent antibiotic use, while maintaining similar patient satisfaction and symptom
outcomes.
B A C K G R O U N D
Description of the condition
The use of antibiotics for acute respiratory tract infections (AR-
TIs) is controversial. Empirical evidence suggests that antibiotics
have only a modest benefit in acute otitis media (AOM) (Glasziou
2004), pharyngitis (Del Mar 2009), and acute bronchitis (Fahey
2004), and no effect in the common cold (Arroll 2005). Any ben-
efits have to be weighed up against common adverse reactions (in-
cluding rash, abdominal pain, diarrhoea and vomiting), and cost
(Berman 1997; Niemela 1999). Over-prescribing may also con-
tribute to community bacterial resistance to antibiotics (Arason
1996; Brook 1998; Verkatesum 1995).
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Description of the intervention
There has been interest in strategies to reduce antibiotic prescrib-
ing for ARTIs. One of these strategies is to advise patients to “de-
lay” filling their script, and only to fill it if their symptoms per-
sist or deteriorate. Delayed antibiotics are advocated as a means of
demonstrating to patients that antibiotics are not always necessary,
without making them feel under-serviced (Arroll 2002b).
How the intervention might work
A systematic review showed that using delayed antibiotics in AR-
TIs significantly reduces antibiotic prescribing. Arroll 2003 The
reduction ranges from a RR 0.77 (95% confidence interval (CI)
0.73 to 0.81) (Dowell 2001) to RR 0.25 (95% CI 0.19 to 0.34)
(Little 1997).
Why it is important to do this review
The delayed antibiotic strategy has also been advocated more re-
cently as a safety net for avoiding rare but important complica-
tions of initially uncomplicated ARTIs (Little 2005b). The same
authors also advocated delayed antibiotics for reducing antibiotic
use, allowing adequate control of symptoms, while providing high
levels of patient satisfaction (Little 2005b).
This review asks specifically what effect delayed antibiotics have
on clinical outcomes of ARTIs compared to immediate antibiotics
and no antibiotics. This review also evaluates the available data
on antibiotic use and patient satisfaction for the three prescribing
strategies of delayed antibiotics, immediate antibiotics and no an-
tibiotics.
O B J E C T I V E S
To evaluate the use of delayed antibiotics compared to immediate
or no antibiotics as a prescribing strategy for ARTIs. We also eval-
uated the outcomes of antibiotic use, patient satisfaction and re-
consultation rates and use of alternative therapies.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) studying the treatment of
ARTIs with delayed antibiotics versus immediate or no antibiotics.
Open randomised trials were accepted.
Types of participants
Patients of all ages defined as having ARTIs.
Types of interventions
1. ’Delayed antibiotic use’ was defined as the use of, or advice
to use, antibiotics more than 48 hours after the initial
consultation.
2. ’Immediate antibiotic use’ was defined as the immediate use
of a prescription of oral antibiotics given at the initial
consultation.
3. ’No antibiotic use’ was defined as no prescription of
antibiotics at the initial consultation.
Types of outcome measures
Primary outcomes
We compared delayed antibiotics with immediate antibiotics and
delayed antibiotics with no antibiotics where data are available.
1. Clinical outcomes for sore throat, AOM, bronchitis
(cough) and common cold. (We will include duration and
severity measures the following symptoms; pain, malaise, fever,
cough and rhinorrhea
2. Antibiotic use
3. Patient satisfaction (where patient satisfaction is measured
on a five-point Likert scale. We defined satisfaction as including
both satisfied and very satisfied.)
Secondary outcomes
1. Adverse effects of antibiotics
2. Complications of disease
3. Re-consultation
4. Use of alternative therapies
Search methods for identification of studies
Electronic searches
In this updated review we searched the Cochrane Central Register
of Controlled Trials (CENTRAL) (The Cochrane Library 2009,
issue 1), which includes the Acute Respiratory Infection Groups’
Specialised Register; Ovid MEDLINE (January 1966 to March
Week 3 2009); EMBASE (1990 to 2009 Week 12); and Current
Contents (1998 to December 2007), Science Citation Index -
Web of Science (January 2007 toMarch 2009); EBSCOCINAHL
(1982 to March Week 4 2009).
In the original version of this review MEDLINE was searched us-
ing the following keywords and MeSH terms in conjunction with
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the highly sensitive search strategy designed by the Cochrane Col-
laboration for identifying randomised controlled trials (Dickersin
1994). For this update no trial filters were applied. The MED-
LINE search strategy was used to search CENTRAL and adapted
to search Ovid EMBASE (see Appendix 1), ISI Science Citation
Index(see Appendix 2) and EBSCO CINAHL (see Appendix 3).
MEDLINE (Ovid)
1 exp Respiratory Tract Infections/
2 (upper respiratory tract infection$ or urti).mp
3 exp Otitis Media/
4 otitis media.mp
5 exp PHARYNGITIS/
6 pharyngitis.mp
7 exp TONSILLITIS/
8 tonsillitis.mp
9 exp Common Cold/
10 common cold.mp
11 Bronchitis/
12 bronchitis.mp
13 exp SINUSITIS/
14 sinusitis.mp
15 sore throat$.mp
16 or/1-15
17 exp Anti-Bacterial Agents/
18 antibiotic$.mp
19 or/17-18
20 (delay$ adj15 prescri$).mp.
21 16 and 19 and 20
There were no language or date of publication restrictions in any
of the electronic database searches.
Searching other resources
Abstracts from the search results were scanned to identify trials
that looselymet the inclusion criteria. The references of all relevant
retrieved trials were checked to identify any other articles.
Data collection and analysis
Selection of studies
Abstracts from the initial search results were scanned to identify
trials that loosely met the inclusion criteria. The references of all
relevant retrieved trials were checked to identify any other articles.
The full text articles of the retrieved trials were then reviewed by
three review authors (RF, LD and CDM) and the inclusion criteria
applied independently.
In this updated review two review authors (LD, CDM) indepen-
dently assessed the methodological quality of the new included
study that met the inclusion criteria (Chao 2008).
Data extraction and management
In the initial publication of this review, three review authors (RF,
LDandCDM) independently extracted data for each study trial to
be included. Extraction was undertaken blinded. Additional data
were extracted from graphs of the published articles of El-Daher
1991 and Pichichero 1987 on fever severity and symptom scores.
In this updated review two review authors (LD, CDM) indepen-
dently extracted data for the new included study.
Assessment of risk of bias in included studies
In the first publication of this review three review authors (RF, LD
and CDM) independently assessed the quality of each of the study
trials that met the inclusion criteria. Disagreements were resolved
by consensus. Assessment was blinded (that is, without the knowl-
edge of the study results, the names of the authors, institutions,
or journal of publication).
The quality of each eligible RCT was rated according to the risk
of bias tool available in RevMan 5 and criteria set out in the
Cochrane Handbook of Systematic Reviews of Interventions (Higgins
2008). Methodological quality was assessed under the headings of
allocation, blinding, incomplete outcome data, selective reporting
and other potential sources of bias.
Two review authors (LD, CDM) independently assessed the
methodological quality of the new included trial for this review
update. Any disagreement between the review authors was resolved
by discussion.
Measures of treatment effect
Data were analysed using RevMan 5. Continuous data compar-
isons were expressed using mean differences where there was one
study or standardised mean difference where more than one study
used different measurement scales. Dichotomous data were ex-
pressed using odds ratios. Data were pooled into clinical outcomes
where multiple trial results for the same clinical presentation ex-
isted and there was no heterogeneity.
Unit of analysis issues
The unit of analysis for each outcome are the individual research
participants.
Dealing with missing data
Six studies included an intention-to-treat (ITT) analysis. Three
other studies described their minimal drop-out rates. One study
(El-Daher 1991) did not discuss the drop-out rate, though it was
small.
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Assessment of heterogeneity
Meta-analysis was not undertaken for most clinical outcomes ow-
ing tomultiple analyses with only one or two study results. Results
were pooled where satisfactorily low I2 statistics and non-signif-
icant chi2 test results were found. Meta-analysis was not under-
taken for antibiotic use owing to heterogeneity of included study
results likely owing to different antibiotic indications for different
clinical presentations.
Assessment of reporting biases
Two studies collected data on clinical outcomes yet did not report
them in detail (Dowell 2001; Gerber 1990). In both cases, the
studies reported that there was no difference between control and
intervention groups.
Data synthesis
Results were pooled where satisfactorily low I2 statistics and non-
significant chi2 test results were found. Meta-analsysis was under-
taken for the outcomes of fever for sore throat and patient satis-
faction.
Subgroup analysis and investigation of heterogeneity
Heterogeneity was measured using chi2and I2 statistics and found
to be significant for the outcomes related to antibiotic use. Het-
erogeneity was less likely to be important for the outcomes related
to patient satisfaction.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
Of the 167 RCTs identified by electronic searching, 23 were re-
trieved for more detailed evaluation. None of the remaining trials
were excluded following quality appraisal. One new trial was in-
cluded in this update (Chao 2008) such that 10 trials were eligible
for inclusion. The 10 trials included 1159 participants in their
delayed antibiotic arm, with 1067 participants in the immediate
antibiotic arm of nine trials and 465 participants in the no antibi-
otic arms of three trials.
Included studies
There was only one trial which compared delayed antibiotics with
none (Chao 2008).
Nine compared immediate antibiotics with delayed antibiotics.
Four of these trials investigated acute pharyngitis/sore throat; two
with AOM; two with cough and one dealt with the common
cold. Early studies of sore throat (El-Daher 1991; Gerber 1990;
Pichichero 1987)were designed as efficacy trials to identify the rate
of relapse of Group A beta-haemolytic streptococcus (GABHS)
throat in immediate versus delayed antibiotic groups. Subsequent
trials (Arroll 2002a; Dowell 2001; Little 1997; Little 2001; Spiro
2006) comparing delayed antibiotics and immediate antibiotics
were conducted with a view to evaluating the use of delayed an-
tibiotics to reduce the use of antibiotics for upper RTIs.
Three studies compared the prescribing strategy of no antibiotics
with delayed antibiotics (Chao 2008; Little 1997; Little 2005a).
These three trials investigated the presentations of sore throat Little
1997, cough Little 2005a and AOM Chao 2008. This last study
(Chao 2008) also asked patients in the no antibiotic arm to return
if their symptoms had not resolved.
Excluded studies
Two trials were excluded. One because it used a before and after
study design (Cates 1999) and one was not randomised.
Risk of bias in included studies
Summaries of the bias in included studies are provided in Figure
1 and Figure 2.
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Figure 1. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Allocation
Eight included studies were adequately randomised using ran-
dom number tables or computer generated randomisation. For
two studies themethod of randomisation was not described (Little
1997; El-Daher 1991). Only four trials described adequate allo-
cation concealment using opaque envelopes (Arroll 2002a; Little
2001; Little 2005a; Spiro 2006)
Blinding
Three studies attempted to blind the patient and the doctor with-
out mention of the outcome assessor (Arroll 2002a; El-Daher
1991; Pichichero 1987). Seven studies had attempted to blind
some or all aspects of the study; that is, the patients, the doctor
and the outcome assessor.
For four studies (Chao 2008; Dowell 2001; Little 2005a; Spiro
2006), the outcomes assessor was blinded but not the patient nor
the care giver.
For the remaining three studies no blinding was undertaken (
Gerber 1990; Little 1997; Little 2001).
Incomplete outcome data
Only one trial (El-Daher 1991) had incomplete outcome data and
did not adequately address it.
Selective reporting
Only one trial (Gerber 1990) reported collecting important in-
formation (in this case related to clinical outcomes) without fully
reporting it.
Other potential sources of bias
No other sources of bias were identified.
Effects of interventions
For most outcomes meta-analyses were not possible: some studies
did not describe their data in sufficient detail; and others were too
heterogeneous to safely allow meta-analysis. Therefore, few forest
plots have more than one study. Table 1 summarises the statistical
outcomes available for each study. However, for patient satisfac-
tion, data were available and homogenous, so pooled results using
a random-effects model are presented. For sore throat, two trials
with minimal heterogeneity have been pooled for the outcome of
fever severity on Day 3.
Results are outlined under the headings of clinical outcomes, an-
tibiotic use and patient satisfaction in order to reflect the impor-
tant clinical considerations relevant to the strategy of prescribing
delayed antibiotics. The strategy of delayed antibiotics is compared
to the strategies of immediate antibiotics and no antibiotics, de-
pending on the available data. For each illness category there is at
least one RCT (for example, common cold) with a maximum of
four (sore throat). Given the low numbers of trials for each illness
category, conclusions for illness categories need to be treated with
caution. Clinical outcomes are stratified by illness owing to known
differences in the effect of antibiotics on different types of respi-
ratory infections. Antibiotic use and patient satisfaction data have
been presented without this stratification as they are less likely to
be affected by illness type and to show more clearly the effect of
prescribing strategies.
Clinical Outcomes
See Table 1.
Sore throat
Four included studies examined sore throat (El-Daher 1991;
Gerber 1990; Little 1997; Pichichero 1987).
Delayed antibiotics versus immediate antibiotics
Pain was reduced on Day three in the immediate antibiotic group
compared to delayed antibiotics in one study (Analysis 1.1). Pain
was not significantly different between delayed and immediate
antibiotic groups in three studies (Gerber 1990; Little 1997;
Pichichero 1987).
Malaise was reduced on Day three in the immediate antibiotic
group compared to delayed antibiotics in one study (Analysis 2.1)
and no difference was found in the other study measuring this
outcome (Analysis 2.2).
Fever severity onDay three was reducedwith immediate antibiotics
compared to delayed antibiotics in two studies (pooled results OR
0.53 (95% CI 0.31 to 0.74) (Analysis 3.1). The number of days
with fever was reduced in the immediate antibiotic group of Little
1997 and therewas nodifference found in the fourth study (Gerber
1990).
Delayed antibiotics versus no antibiotics
One study examining sore throat compared the prescribing strat-
egy of delayed antibiotics with no antibiotics (Little 1997). This
study found no difference in any clinical outcome between these
two prescribing strategies.
Complications
Data on complications of sore throat such as rheumatic fever, post-
streptococcal glomerulonephritis and peri-tonsillar abscess were
not reported in any of the four studies looking at sore throat for
the three prescribing strategies of immediate, delayed and no an-
tibiotics.
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AOM
Three included trials examined AOM (Chao 2008; Little 2001;
Spiro 2006).
Delayed antibiotics versus immediate antibiotics
Pain and malaise were greater using delayed antibiotics compared
to immediate antibiotics in one studymeasuring these outcomes on
Day three (Analysis 4.1). One study examined clinical outcomes
on Days four to six and found no difference (Analysis 5.1) .
Other proxies for malaise outcomes reported by Little 2001 in-
cluded last day of crying which favoured the immediate antibiotic
group by approximately 16 hours in children with AOM (0.69
days; 95% CI 0.31 to 0.07). In the same study, just over half a
spoon of paracetamol a day less was used in the immediate an-
tibiotic group (0.59; 95% CI 0.25 to 0.93). On Day one there
were no significant differences between immediate and delayed an-
tibiotic groups in symptom outcome measures and by Day seven
there was no difference between immediate and delayed antibiotic
groups (Little 2001).
Further analysis of ear ache and function from one trial (Little
2001) found no difference between delayed and immediate groups
at three and 12 months for these two outcomes (Little 2006).
Delayed antibiotics versus no antibiotics
Only one study compared delayed antibiotics with no antibiotics
with no significant difference for pain or fever on Day three (
Analysis 8.1, Analysis 9.1). This trial also advised participants in
the no antibiotic arm to represent in two to three days if symptoms
did not resolve.
Complications
Data on complications of AOM such as mastoiditis, rheumatic
fever and post-streptococcal glomerulonephritis were not reported
from any of the three studies looking at AOM for the prescribing
strategies of immediate and delayed antibiotics. However, Spiro
2006 and Chao 2008 noted that there were no serious adverse
events for participants in the study.
Bronchitis (cough)
Two studies examined the prescribing strategies of immediate
versus delayed antibiotics for the clinical presentation of cough
(Dowell 2001; Little 2005a) and neither found any difference in
clinical outcomes, including fever and cough.
Complications
Little 2005a also looked at delayed antibiotics versus no antibiotics
and found no difference in clinical outcomes between the two
prescribing strategies. One patient in the no antibiotic group (out
of 273) of this study developed pneumonia and recovered with
antibiotics in hospital.
Dowell 2001 did not report on complications in the immediate
and delayed antibiotic groups.
Common cold
One study looked at immediate antibiotics versus delayed antibi-
otics (Arroll 2002a) and found no difference between the two pre-
scribing strategies for the clinical outcomes of fever, cough, pain
and malaise (Analysis 10.1; Analysis 11.4; Analysis 12.1).
Antibiotic use
See Table 1.
Delayed antibiotics
The three studies included in this systematic review published
prior to 1992 examined the concern that immediate antibiotics
for streptococcal pharyngitis might impair the body’s immune re-
sponse and predispose the patient to a relapse of pharyngitis. Com-
pliance in both immediate and delayed antibiotic groups was close
to 100%. Six of the included studies published after 1992 were
conducted to evaluate the role of delayed antibiotics as a way of
reducing antibiotic use for respiratory infections compared to im-
mediate antibiotics. All six studies found that antibiotic use was
significantly reduced in the delayed antibiotic group compared
to the immediate antibiotic group. There were significant differ-
ences in the way antibiotics were delayed which resulted in marked
heterogeneity of this result. Of the seven studies published after
1991, four had the delayed script kept at reception to be picked
up (Dowell 2001; Little 1997; Little 2001; Little 2005a) and in
three, the script was issued to patients with instructions to delay
(Arroll 2002a; Chao 2008; Spiro 2006). For the delayed arms of
the four studies where the script was left at reception, antibiotics
were used in 28% of cases (173/618) compared with antibiotics
being used in 40% of cases (122/305) where antibiotics were is-
sued to patients with instructions to delay.
Overall, the seven trials post 1992 providing a delayed antibiotic
arm found 295 prescriptions filled out of 923 participants (32.0%)
Immediate antibiotics (Analysis 13.1)
Six trials published post 1992 provided immediate antibiotic arms
examining this outcome resulting in 790 participants filling pre-
scriptions out of 847 participants (93.3%).
No antibiotics (Analysis 14.1)
Three studies compared delayed antibiotics with no antibiotics.
Little 1997 found that there was less antibiotic use with the no
antibiotic strategy compared to delayed antibiotics. Little 2005a
found no differences. Chao 2008 is themost recent and only study
conducted comparing delayed antibiotics only with no antibiotics
and also found that less antibiotics were prescribed in the no an-
tibiotic group (Analysis 14.1).
Overall, 65 patients filled scripts out of 466 participants (13.9%).
Patient satisfaction
See Table 1.
Delayed antibiotics versus immediate antibiotics (Analysis 15.1)
Patient satisfaction has been measured in five out of seven stud-
ies evaluating the prescribing strategy of delayed antibiotics since
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1992 (Arroll 2002a; Dowell 2001; Little 1997; Little 2001; Little
2005a). Two of these studies indicated that study participants were
more satisfied with the strategy of immediate antibiotics than de-
layed antibiotics (Little 2001; Little 2005a). There was no differ-
ence found in the other three studies (Arroll 2002a; Dowell 2001;
Little 1997). The pooled result for this outcome with these five
studies was an odds ratio of 0.52 (95% CI: 0.35, 0.76) favour-
ing immediate antibiotics. Fixed- and random-effects analyses gave
similar results. A breakdown of the trials by blinding gave two
trials (Dowell 2001; Little 2005a) which blinded the outcome as-
sessor and one blinded the patient and the doctor (Arroll 2002a)
to give an odds ratio for all three studies of 0.62 (95% CI 0.38
to 1.01). The two completely unblinded trials (Little 1997; Little
2001) give an odds ratio of 0.42 (95% CI 0.22 to 0.78). Overall
92% of the participants in the immediate antibiotics arms were
satisfied versus 87% in the delayed arms.
Delayed antibiotics versus no antibiotics (Analysis 16.1)
Three studies examined patient satisfaction comparing the pre-
scribing strategies of delayed antibiotics and no antibiotics (Chao
2008; Little 1997; Little 2005a). While there was no difference in
patient satisfaction for any of these studies, the pooled result for
these three studies was an odds ratio of 1.44 (95%CI 0.99 to 2.10)
showing no statistically significant difference. Fixed- and random-
effects analyses gave similar results. A breakdown of the trials by
blinding gave two trials (Chao 2008; Little 2005a) which blinded
the outcome assessor to give an odds ratio for these two trials of
1.42 (95% CI 0.92 to 2.19). The one completely unblinded trial
(Little 1997) gave an odds ratio of 1.49 (95% CI 0.70 to 3.19).
In the delayed antibiotic arm 413 of participants were satisfied or
very satisfied out of 473 participants (87.3%) compared to 387
out of 465 participants in the no antibiotics group (83.2%).
Adverse effects of antibiotics
Adverse effects are considered under different clinical headings
owing to differences in antibiotic prescribing recommendations
for each condition. This is likely to have contributed to the het-
erogeneity evident in the forest plots for these outcomes prevent-
ing pooling of results. Adverse results are presented graphically
for delayed versus immediate antibiotics (Analysis 17.1; Analysis
17.2; Analysis 17.3; Analysis 18.4) and delayed versus no antibi-
otics (Analysis 18.1; Analysis 18.2; Analysis 18.3; Analysis 18.4).
Sore throat
Delayed antibiotics versus immediate antibiotics
One study (Little 1997) found no difference for diarrhoea, vomit-
ing, rash and stomach ache. El-Daher 1991 found more vomiting
in the delayed group compared to the immediate antibiotics.
Delayed antibiotics versus no antibiotics
One study (Little 1997) found no difference between for diar-
rhoea, vomiting, rash and stomach ache.
AOM
Delayed antibiotics versus immediate antibiotics
Little 2001 and Spiro 2006 found reduced diarrhoea in the delayed
antibiotic group. Spiro 2006 did not find any difference between
delayed and immediate antibiotics for vomiting, and Little 2001
found no difference for the outcome of rash.
Delayed antibiotics versus no antibiotics
There were no adverse events in either group reported by Chao
2008.
Bronchitis (cough)
Delayed antibiotics versus immediate antibiotics
Little 2005a found no difference for adverse effects.
Delayed antibiotics versus no antibiotics
Little 2005a found no difference for adverse effects.
Common cold
Delayed antibiotics versus immediate antibiotics
There was no significant difference between the groups for diar-
rhoea, a potential adverse effect of antibiotics (Arroll 2002a).
Re-consultation rates
Re-consultation rates were the same between delayed and immedi-
ate antibiotic groups in two studies (Analysis 19.1). Participants
with sore throat in one study were more likely to intend to consult
again if they received immediate antibiotics compared to delayed
antibiotics (Little 1997).
D I S C U S S I O N
Summary of main results
Small differences were found between prescribing strategies for
clinical outcomes with immediate antibiotics most likely to show
benefit over delayed antibiotics in participants with sore throat and
AOM. All strategies appear to have similar safety with no advan-
tage found for delayed antibiotics over no antibiotics for disease
complications. Delay and no antibiotic strategies dramatically re-
duce the use of antibiotics for ARTIs compared to immediate an-
tibiotics. The least antibiotic use was in the no antibiotic group
followed by delay and then immediate.The number needed to treat
to prevent one antibiotic prescription using the delay strategy is
1.6 compared to immediate antibiotics. The number needed to
treat to prevent one antibiotic prescription using a no antibiotic
strategy compared to delay is 5.6. Patient satisfaction was highest
in the immediate antibiotic group with 92.2% being satisfied or
very satisfied with the consultation. The delay and no groups had
similar quite high satisfaction rates at 87.3% and 83.2%, respec-
tively.
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Overall completeness and applicability of
evidence
Studies comparing delayed and immediate antibiotics have been
performed for two different motives. The studies of Pichichero
1987, Gerber 1990 and El-Daher 1991 were concerned that im-
mediate antibiotics for streptococcal pharyngitis might impair the
body’s immune response and predispose the patient to a relapse
of pharyngitis. These studies are useful for determining the effect
of delayed versus immediate antibiotics on the clinical course of
suspected streptococcal pharyngitis. Six of the remaining studies
were conducted to determine if the strategy of delayed antibiotics
reduces the number of prescriptions filled for upper ARTIs (Arroll
2002a; Dowell 2001; Little 1997; Little 2001) while maintaining
patient safety and satisfaction. The most recent study may indi-
cate evolution in prescribing habits as it was the first to drop the
immediate antibiotic arm (Chao 2008).
Useful data were collected for many symptom outcomes in all
studies but were not always reported in a way that could be anal-
ysed. This problem was partially overcome by obtaining raw data
from some trial authors. The seven studies conducted after 1992
all reported useful data on antibiotic use and six on patient satis-
faction.
There are only three trials comparing delayed antibiotics with no
antibiotics.
Quality of the evidence
All but one trial El-Daher 1991 were adequately randomised and
accounted for incomplete data. El-Daher 1991 did find large dif-
ferences for clinical outcomes for sore throat in favour of immedi-
ate antibiotics compared to delayed antibiotics.
This intervention does not lend itself to blinding. However, three
trials attempted to blind patients and doctors (Arroll 2002a; El-
Daher 1991; Pichichero 1987). For four studies (Chao 2008;
Dowell 2001; Little 2005a; Spiro 2006), the outcomes assessor
was blinded but not the patient nor the care giver.
Otherwise, studies were well reported and appeared to be high
quality.
Potential biases in the review process
Heterogeneity of RCTs is the main limitation of this review. Het-
erogeneity may have resulted from variable clinical presentations,
differences in delaymethod, differences in antibiotic use and qual-
ity of included studies. Type I error is a concern when interpreting
the results of this review, given the heterogeneity of results with
multiple outcome measures. This is especially concerning for the
comparisons for clinical outcomes between delayed and immediate
antibiotic groups.
Agreements and disagreements with other
studies or reviews
Some doctors use the delay strategy to reduce antibiotic use, em-
power patients, and save the patient time andmoneywithout jeop-
ardizing the doctor-patient relationship (Arroll 2002b). Findings
for certain clinical outcomes in our review might have been antici-
pated. Systematic reviews on antibiotics for sore throat and AOM
found that their time of greatest benefit for symptoms is apparent
at Days three or four after treatment has started (Del Mar 2009;
Glasziou 2004). Thus delaying antibiotics by 48 hours or more
would overshoot this zenith. Nor is it surprising that we found
more adverse reactions to antibiotics from immediate antibiotics
in line with known adverse events from comparison RCTs with no
antibiotics.
The greatest difference in clinical outcomes was found in the only
trial of delayed antibiotics conducted in a low socio-economic en-
vironment, favouring immediate antibiotics over delay ( El-Daher
1991). This trial was also the least methodologically sound, but
it highlighted that concerns expressed about delayed antibiotics
for children, the elderly (Datta 2008) and those with language or
cultural difficulties (Johnson 2007) may also need to be extended
to low socio-economic populations.
A parallel RCT of patients with acute infective conjunctivitis sim-
ilarly reported shortest symptom duration with immediate, fol-
lowed by delayed and then no antibiotics (the last resulting in least
antibiotic use). There was no difference between the groups for
patient satisfaction (Everitt 2006).
RCTs comparing delayed with no antibiotics (concluding that they
were both equally acceptable alternatives to immediate antibiotics
as a means of reducing antibiotic prescriptions (Little 2001; Little
2005a) led to recommending delayed instead of no antibiotics to
address concerns about risks of complications (Little 2005b).Doc-
tors worried about the risk of serious infective complications con-
sequent to adopting a no antibiotic rather than delayed strategy
might take comfort from a UK observational study showing that
reduced prescribing resulted in no increase in admissions to hos-
pital for peri-tonsillar abscess or rheumatic fever (Sharland 2005),
although mastoiditis might be at risk at the rate of 2500 children
needing to be treated with antibiotics to prevent one case (Van
Zuijlen 2001). Thirty-five per cent of parents in the AOM trials
(Chao 2008; Little 2001; Spiro 2006) used their delayed script
suggesting that the number of delayed scripts required to prevent
one case of mastoiditis would be significantly higher than 2500.
Doctors often find it difficult to identify patients at risk of serious
complications from respiratory infections (Kumar 2003). Patients
probably perform even less well, despite their self-confidence in
making this decision if given a delayed antibiotic prescription. This
is a dissociation supported by empirical data: respiratory disease
severity does not correlate with patients’ immediate preference for
an antibiotic prescription (Macfarlane 1997). This review did not
find any significant difference for complication rates between pre-
scribing strategies.
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There is little controversy within published guidelines that imme-
diate antibiotics are recommended for patients who appear to be
seriously unwell, fitmultiple criteria indicating bacterial tonsillitis,
are under six months of age with AOM, have bilateral AOM or
have AOM with otorrhoea (Tan 2008). American guidelines also
recommend immediate antibiotics for childrenunder twowith def-
inite AOM (Otitis Media Treatment Guidelines 2004). It seems
then that for themajority of respiratory infections that do notmeet
these criteria, clinicians have the option of delayed or no antibi-
otics. It seems clear that no antibiotics will result in least antibiotic
use and therefore less antibiotic resistance. Concerns about patient
and doctor satisfaction with no antibiotics appear to be driving the
use of a delayed strategy. Shared decision-making (Butler 2001;
Legare 2007) and education campaigns for doctors (Sung 2006)
have been proposed as ways of helping doctors and patients avoid
unnecessary antibiotic use. One suggestion is that delayed antibi-
otics may in time become redundant as doctors and their patients
gain more reassurance in the safety of not using antibiotics (Arroll
2003b).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Immediate antibiotics is more likely to confer the modest benefits
of antibiotics on clinical outcomes such as symptoms for AOM
and sore throat than delayed antibiotics. There were no differences
in complication rates between immediate and delayed antibiotics
nor between delayed and no antibiotics. Immediate antibiotics had
slightly higher levels of patient satisfaction than delayed antibiotics
which reached statistical significance but is of marginal clinical
significance (92% versus 87%). Patient satisfaction was similarly
high in the delayed and no antibiotic groups with a trend towards
delayed antibiotics that was neither statistically nor clinically sig-
nificant (87% versus 83%). Delayed antibiotic prescribing strate-
gies achieved lower rates of antibiotic use compared to immedi-
ate antibiotics (32% versus 93%). No antibiotics achieved lower
rates of antibiotics use compared to delayed antibiotics (13% ver-
sus 32%).
Delayed antibiotics for respiratory infections is a strategy which
reduces antibiotic use compared to immediate antibiotics but has
not been shown by this review to be different to no antibiotics
in terms of symptom control and disease complications. In pa-
tients with respiratory infections where clinicians feel it is safe not
to prescribe antibiotics immediately, no antibiotics with advice to
return if symptoms do not resolve is likely to result in the least
antibiotic use, while maintaining similar patient satisfaction and
clinical outcomes to delayed antibiotics.
Implications for research
Further research into antibiotic prescribing strategies for respira-
tory infections may best be focused on identifying patient groups
at high risk of disease complications, enhancing doctors’ commu-
nication with patients to maintain satisfaction and ways of reduc-
ing doctors’ anxieties about not prescribing antibiotics for respi-
ratory infections. Future RCTs of delaying antibiotics as an inter-
vention should fully report symptoms, patient satisfaction, doctor
satisfaction and disease complications as well as changes in pre-
scription rates. They should also include a no antibiotic arm.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by year of study]
Pichichero 1987
Methods Open randomised controlled trial
Participants Children with sore throat (suspected Group A Beta Haemolytic Streptococcus)
Interventions Delayed antibiotics (48 hours) versus immediate antibiotics (penicillin 250 mg tds for 10
days)
Outcomes Fever, duration of fever, malaise, re consultation rates, vomiting
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Table of random numbers
Allocation concealment? No D - Not used
Blinding?
All outcomes
Yes Patient and Doctor blinded but unsure re outcome
assessor
Incomplete outcome data addressed?
All outcomes
Yes No drop outs
Free of selective reporting? Yes prespecified outcomes were reported
Free of other bias? Yes
Gerber 1990
Methods Randomised controlled trial
Participants Adults and childrenwith sore throat (suspectedGroupABetaHaemolytic Streptococcus)
Interventions Delayed antibiotics (48 hours) versus immediate antibiotics (penicillin V, 250 mg qds for
10 days)
Outcomes Malaise
Notes
Risk of bias
15Delayed antibiotics for respiratory infections (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gerber 1990 (Continued)
Item Authors’ judgement Description
Adequate sequence generation? Yes Random number table
Allocation concealment? No
Blinding?
All outcomes
No No blinding
Incomplete outcome data addressed?
All outcomes
Yes Drop outs described
Free of selective reporting? Unclear Clinical outcomes reported as one outcome
Free of other bias? Yes
El-Daher 1991
Methods Randomised controlled trial
Participants Children with sore throat (suspected Group A Beta Haemolytic Streptococcus)
Interventions Delayed antibiotics (48 hours) versus immediate antibiotics (penicillin V 50,000 iu/kg/
day)
Outcomes Pain, malaise, vomiting, temperature
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Method not described
Allocation concealment? No Not described
Blinding?
All outcomes
Yes Blinding of patient and care provider but unsure re out-
come assessor
Incomplete outcome data addressed?
All outcomes
No Drop-outs not described
Free of selective reporting? Yes Prespecified outcomes reported
Free of other bias? Yes
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Little 1997
Methods Open randomised controlled trial
Participants Adults and children with sore throat
Interventions Delayed antibiotics (script left at reception and patients instructed to pick it up 72 hours
later if required) versus immediate antibiotics versus no antibiotics (penicillin V 250 mg
qds in both groups)
Outcomes Fever, cough, duration of pain, duration of malaise, absence from school, diarrhoea and
rash
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Randomisation method not described
Allocation concealment? Unclear “Sealed envelopes” no mention of opacity
Blinding?
All outcomes
No
Incomplete outcome data addressed?
All outcomes
Yes ITT analysis undertaken
Free of selective reporting? Yes
Free of other bias? Yes
Dowell 2001
Methods Randomised controlled trial
Participants Adults and children with cough
Interventions Delayed antibiotics (script left at reception and patients instructed to pick up the script
after one week of delay) versus immediate antibiotics (antibiotic of GP’s choice)
Outcomes Duration of cough, antibiotic use
Notes
Risk of bias
Item Authors’ judgement Description
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Dowell 2001 (Continued)
Adequate sequence generation? Yes Random number table
Allocation concealment? Unclear Numbered envelopes (opacity not mentioned)
Blinding?
All outcomes
No Outcome Assessor blinded but not patient nor care
provider
Incomplete outcome data addressed?
All outcomes
Yes Drop out numbers were described and intention to treat
analysis used
Free of selective reporting? Yes Pre-specified clinical outcomes were not published but
authors provided this information
Free of other bias? Yes
Little 2001
Methods Pragmatic randomised controlled trial
Participants Children aged 6 months to 10 years with AOM
Interventions Delayed antibiotics (72 hours) versus immediate antibiotics (amoxicillin 250 mg tds for
one week)
Outcomes Fever, severity of pain, duration of malaise, absence from school, use of paracetamol,
antibiotic use
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Quote: ”patients were randomised to a group“
Allocation concealment? Yes Quote: ”doctor opened a sealed numbered
opaque envelope
Blinding?
All outcomes
No No blinding undertaken
Incomplete outcome data addressed?
All outcomes
Yes A comparison of responders versus non-re-
sponders was undertaken
Free of selective reporting? Yes Pre-specified outcomes have been reported
Free of other bias? Yes
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Arroll 2002a
Methods Randomised controlled trial
Participants Adults and children with the common cold
Interventions Delayed antibiotics (patients given script and instructed to fill within 72 hours) versus
immediate antibiotics
Outcomes Fever, duration of fever, cough, duration of cough, pain, absence from school/work,
diarrhoea, antibiotic use
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Randomisation using Excel
Allocation concealment? Yes Yes - opaque envelopes
Blinding?
All outcomes
Yes Patient and care provider were blinded but unsure re-
garding outcome assessor
Incomplete outcome data addressed?
All outcomes
Yes ITT analysis used
Free of selective reporting? Yes Pre-specified outcomes were reported
Free of other bias? Yes
Little 2005a
Methods Randomised controlled trial
Participants Adults and children aged three years and over with cough and at least one symptom or
sign localising to the lower respiratory tract
Interventions Delayed antibiotics (script left at reception and patients instructed to pick up the script
after 14 days if required) versus immediate antibiotics versus no antibiotics
Outcomes Fever, cough, duration of cough, severity of cough, malaise, duration of malaise, com-
plications of disease, hospital admissions, diarrhoea, antibiotic use
Notes
Risk of bias
Item Authors’ judgement Description
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Little 2005a (Continued)
Adequate sequence generation? Yes Computer generated random number tables, and block
randomization (block size 6)
Allocation concealment? Yes Opaque sealed envelopes
Blinding?
All outcomes
No Outcome assessor was blinded. Patient and care provider
were not blinded
Incomplete outcome data addressed?
All outcomes
Yes Missing data were described and intention to treat anal-
ysis used
Free of selective reporting? Yes Pre-specified outcomes were reported
Free of other bias? Yes
Spiro 2006
Methods Placebo and randomised controlled trial
Participants Children aged 6 months to 12 years
Interventions Delayed antibiotics (patients given a script which was to expire after 72 hours) versus
immediate antibiotics
Outcomes Fever, duration of fever, pain, duration of pain, vomiting, diarrhoea, rash, antibiotic use
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Computer assisted randomisation
Allocation concealment? Yes Sealed opaque envelopes
Blinding?
All outcomes
No Study participants were not blinded but out-
come assessors were blinded
Incomplete outcome data addressed?
All outcomes
Yes More people in the wait and see prescription
group stayed in the trial however this was
acknowledges and addressed
Free of selective reporting? Yes Pre-specified outcomes were reported
Free of other bias? Yes
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Chao 2008
Methods Randomised controlled trial
Participants Children with AOM
Interventions No antibiotics (observation) versus delayed antibiotics (observation plus prescription) -
patients given script and instructed to fill the script if required
Outcomes Fever, pain, antibiotic use, patient satisfaction, adverse events
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Random number table
Allocation concealment? No Not described
Blinding?
All outcomes
No Outcome Assessor blinded. Patient and care provider not
blinded
Incomplete outcome data addressed?
All outcomes
Yes Missing data were described and ITT analysis applied
Free of selective reporting? Yes Pre-specified outcomes were reported
Free of other bias? Yes
tds: three times a day
qds: four times a day
iu: international units
ITT: intention-to-treat
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Cates 1999 Non randomised trial. Before and after study
Siegel 2003 Non randomised trial
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D A T A A N D A N A L Y S E S
Comparison 1. Sore throat - pain; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain on Day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Pain severity on Day 3 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 2. Sore throat - malaise; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Malaise on Day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Malaise severity 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 3. Sore throat - fever; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fever severity on Day 3 2 343 Std. Mean Difference (IV, Fixed, 95% CI) 0.53 [0.31, 0.74]
2 Fever severity on Day 1 2 343 Std. Mean Difference (IV, Fixed, 95% CI) -0.07 [-0.29, 0.14]
Comparison 4. AOM - pain; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain on Day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Pain on Days 4 to 6 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Pain on Day 7 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Pain severity on Day 3 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5 Pain severity on Day 7 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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Comparison 5. AOM - malaise; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Malaise on Day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Malaise severity on Day 3 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3 Malaise severity on Day 7 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 6. Supplementary medicine consumption; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Spoons of paracetamol/day 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2 Use of paracetamol and
ibuprofen
1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 7. AOM - fever; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fever Days 4 to 6 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 8. AOM - pain; Delayed versus No Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Otitis media pain on Day 3
delayed versus none
1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
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Comparison 9. AOM - fever; Delayed versus No Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Otitis media number of patients
with fever on Day 3 delayed
versus none
1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
Comparison 10. Common cold - pain; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain on Day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Pain on Day 7 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 11. Common cold - fever; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fever on Day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Fever on Day 7 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Fever severity on Day 1 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4 Fever severity on Day 3 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5 Fever severity on Day 7 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 12. Common cold - cough; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Cough on Day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Cough on Day 7 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
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Comparison 13. Antibiotic use; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Antibiotic use: immediate versus
delayed antibiotics
6 Odds Ratio (M-H, Random, 95% CI) Totals not selected
Comparison 14. Antibiotic use; Delayed versus No Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Antibiotic use: delayed versus no
antibiotics
3 Odds Ratio (M-H, Random, 95% CI) Totals not selected
Comparison 15. Patient satisfaction; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient satisfaction: Delayed
versus Immediate Antibiotics
5 1334 Odds Ratio (M-H, Random, 95% CI) 0.52 [0.35, 0.76]
Comparison 16. Patient satisfaction; Delayed versus No Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient satisfaction: delayed
antibiotics versus no antibiotics
3 938 Odds Ratio (M-H, Random, 95% CI) 1.44 [0.99, 2.10]
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Comparison 17. Adverse events: Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Vomiting 3 Odds Ratio (M-H, Random, 95% CI) Totals not selected
2 Diarrhoea 4 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Rash 2 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Stomach ache 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 18. Adverse events: Delayed versus No Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Vomiting 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Diarrhoea 2 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Rash 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Stomach ache 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 19. Re-consultation rate; Delayed versus Immediate Antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Reconsultation rate 2 379 Odds Ratio (M-H, Fixed, 95% CI) 1.04 [0.55, 1.98]
Analysis 1.1. Comparison 1 Sore throat - pain; Delayed versus Immediate Antibiotics, Outcome 1 Pain on
Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 1 Sore throat - pain; Delayed versus Immediate Antibiotics
Outcome: 1 Pain on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
El-Daher 1991 106/118 42/111 14.51 [ 7.14, 29.50 ]
0.01 0.1 1 10 100
Favours delayed antibiotics Favours immediate antibiotics
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Analysis 1.2. Comparison 1 Sore throat - pain; Delayed versus Immediate Antibiotics, Outcome 2 Pain
severity on Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 1 Sore throat - pain; Delayed versus Immediate Antibiotics
Outcome: 2 Pain severity on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Pichichero 1987 55 1.6 (1.38) 59 1.3 (1) 0.30 [ -0.15, 0.75 ]
-10 -5 0 5 10
Favours delayed antibiotics Favours immediate antibiotics
Analysis 2.1. Comparison 2 Sore throat - malaise; Delayed versus Immediate Antibiotics, Outcome 1
Malaise on Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 2 Sore throat - malaise; Delayed versus Immediate Antibiotics
Outcome: 1 Malaise on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
El-Daher 1991 45/118 4/111 16.49 [ 5.68, 47.83 ]
0.005 0.1 1 10 200
Favours delayed antibiotics Favours immediate antibiotics
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Analysis 2.2. Comparison 2 Sore throat - malaise; Delayed versus Immediate Antibiotics, Outcome 2
Malaise severity.
Review: Delayed antibiotics for respiratory infections
Comparison: 2 Sore throat - malaise; Delayed versus Immediate Antibiotics
Outcome: 2 Malaise severity
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Pichichero 1987 55 1.3 (1) 59 1.1 (0.67) 0.20 [ -0.11, 0.51 ]
-10 -5 0 5 10
Favours delayed antibiotics Favours immediate antibiotics
Analysis 3.1. Comparison 3 Sore throat - fever; Delayed versus Immediate Antibiotics, Outcome 1 Fever
severity on Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 3 Sore throat - fever; Delayed versus Immediate Antibiotics
Outcome: 1 Fever severity on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
El-Daher 1991 118 38 (1.96) 111 37.1 (0.95) 66.4 % 0.58 [ 0.31, 0.84 ]
Pichichero 1987 55 37.2 (1.17) 59 36.8 (0.61) 33.6 % 0.43 [ 0.06, 0.80 ]
Total (95% CI) 173 170 100.0 % 0.53 [ 0.31, 0.74 ]
Heterogeneity: Chi2 = 0.40, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 4.80 (P < 0.00001)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours delayed antibiotics Favours immediate antibiotics
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Analysis 3.2. Comparison 3 Sore throat - fever; Delayed versus Immediate Antibiotics, Outcome 2 Fever
severity on Day 1.
Review: Delayed antibiotics for respiratory infections
Comparison: 3 Sore throat - fever; Delayed versus Immediate Antibiotics
Outcome: 2 Fever severity on Day 1
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
El-Daher 1991 118 38.7 (0.65) 111 38.8 (0.53) 66.7 % -0.17 [ -0.43, 0.09 ]
Pichichero 1987 55 38.2 (0.83) 59 38.1 (0.89) 33.3 % 0.12 [ -0.25, 0.48 ]
Total (95% CI) 173 170 100.0 % -0.07 [ -0.29, 0.14 ]
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours delayed antibiotics Favours immediate antibiotics
Analysis 4.1. Comparison 4 AOM - pain; Delayed versus Immediate Antibiotics, Outcome 1 Pain on Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 4 AOM - pain; Delayed versus Immediate Antibiotics
Outcome: 1 Pain on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 2001 28/111 15/101 1.93 [ 0.96, 3.88 ]
0.1 0.2 0.5 1 2 5 10
Favours delayed antibiotics Favours immediate antibiotics
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Analysis 4.2. Comparison 4 AOM - pain; Delayed versus Immediate Antibiotics, Outcome 2 Pain on Days 4
to 6.
Review: Delayed antibiotics for respiratory infections
Comparison: 4 AOM - pain; Delayed versus Immediate Antibiotics
Outcome: 2 Pain on Days 4 to 6
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Spiro 2006 85/132 89/133 0.89 [ 0.54, 1.48 ]
0.1 0.2 0.5 1 2 5 10
Favours delayed antibiotics Favours immediate antibiotics
Analysis 4.3. Comparison 4 AOM - pain; Delayed versus Immediate Antibiotics, Outcome 3 Pain on Day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 4 AOM - pain; Delayed versus Immediate Antibiotics
Outcome: 3 Pain on Day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 2001 3/111 0/101 6.55 [ 0.33, 128.35 ]
0.02 0.1 1 10 50
Favours delayed antibiotics Favours immediate antibiotics
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Analysis 4.4. Comparison 4 AOM - pain; Delayed versus Immediate Antibiotics, Outcome 4 Pain severity on
Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 4 AOM - pain; Delayed versus Immediate Antibiotics
Outcome: 4 Pain severity on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Little 2001 111 2.56 (2.14) 102 1.81 (1.44) 0.75 [ 0.26, 1.24 ]
-10 -5 0 5 10
Favours delayed antibiotics Favours immediate antibiotics
Analysis 4.5. Comparison 4 AOM - pain; Delayed versus Immediate Antibiotics, Outcome 5 Pain severity on
Day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 4 AOM - pain; Delayed versus Immediate Antibiotics
Outcome: 5 Pain severity on Day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Little 2001 111 1.17 (0.75) 101 1.05 (0.38) 0.12 [ -0.04, 0.28 ]
-10 -5 0 5 10
Favours delayed antibiotics Favours Immediate antibiotics
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Analysis 5.1. Comparison 5 AOM - malaise; Delayed versus Immediate Antibiotics, Outcome 1 Malaise on
Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 5 AOM - malaise; Delayed versus Immediate Antibiotics
Outcome: 1 Malaise on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 2001 45/150 19/135 2.62 [ 1.44, 4.76 ]
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
Analysis 5.2. Comparison 5 AOM - malaise; Delayed versus Immediate Antibiotics, Outcome 2 Malaise
severity on Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 5 AOM - malaise; Delayed versus Immediate Antibiotics
Outcome: 2 Malaise severity on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Little 2001 150 0.83 (1.69) 134 0.4 (0.97) 0.43 [ 0.11, 0.75 ]
-10 -5 0 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
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Analysis 5.3. Comparison 5 AOM - malaise; Delayed versus Immediate Antibiotics, Outcome 3 Malaise
severity on Day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 5 AOM - malaise; Delayed versus Immediate Antibiotics
Outcome: 3 Malaise severity on Day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Little 2001 150 2.23 (2) 135 1.54 (1.22) 0.69 [ 0.31, 1.07 ]
-10 -5 0 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
Analysis 6.1. Comparison 6 Supplementary medicine consumption; Delayed versus Immediate Antibiotics,
Outcome 1 Spoons of paracetamol/day.
Review: Delayed antibiotics for respiratory infections
Comparison: 6 Supplementary medicine consumption; Delayed versus Immediate Antibiotics
Outcome: 1 Spoons of paracetamol/day
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Little 2001 149 2.28 (1.67) 133 1.69 (1.22) 0.59 [ 0.25, 0.93 ]
-10 -5 0 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
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Analysis 6.2. Comparison 6 Supplementary medicine consumption; Delayed versus Immediate Antibiotics,
Outcome 2 Use of paracetamol and ibuprofen.
Review: Delayed antibiotics for respiratory infections
Comparison: 6 Supplementary medicine consumption; Delayed versus Immediate Antibiotics
Outcome: 2 Use of paracetamol and ibuprofen
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Spiro 2006 123/132 120/133 1.48 [ 0.61, 3.59 ]
0.1 0.2 0.5 1 2 5 10
Favours delayed antibiotics Favours immediate antibiotics
Analysis 7.1. Comparison 7 AOM - fever; Delayed versus Immediate Antibiotics, Outcome 1 Fever Days 4
to 6.
Review: Delayed antibiotics for respiratory infections
Comparison: 7 AOM - fever; Delayed versus Immediate Antibiotics
Outcome: 1 Fever Days 4 to 6
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Spiro 2006 42/132 46/133 0.88 [ 0.53, 1.47 ]
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
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Analysis 8.1. Comparison 8 AOM - pain; Delayed versus No Antibiotics, Outcome 1 Otitis media pain on
Day 3 delayed versus none.
Review: Delayed antibiotics for respiratory infections
Comparison: 8 AOM - pain; Delayed versus No Antibiotics
Outcome: 1 Otitis media pain on Day 3 delayed versus none
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chao 2008 26/106 29/100 0.80 [ 0.43, 1.48 ]
0.01 0.1 1 10 100
Favours delayed antibiotics Favours no antibiotics
Analysis 9.1. Comparison 9 AOM - fever; Delayed versus No Antibiotics, Outcome 1 Otitis media number
of patients with fever on Day 3 delayed versus none.
Review: Delayed antibiotics for respiratory infections
Comparison: 9 AOM - fever; Delayed versus No Antibiotics
Outcome: 1 Otitis media number of patients with fever on Day 3 delayed versus none
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chao 2008 18/106 8/100 2.35 [ 0.97, 5.69 ]
0.01 0.1 1 10 100
Favours Delayed antibiotics Favours No antibiotics
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Analysis 10.1. Comparison 10 Common cold - pain; Delayed versus Immediate Antibiotics, Outcome 1 Pain
on Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 10 Common cold - pain; Delayed versus Immediate Antibiotics
Outcome: 1 Pain on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 13/61 9/58 1.47 [ 0.58, 3.77 ]
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
Analysis 10.2. Comparison 10 Common cold - pain; Delayed versus Immediate Antibiotics, Outcome 2 Pain
on Day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 10 Common cold - pain; Delayed versus Immediate Antibiotics
Outcome: 2 Pain on Day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 1/61 3/58 0.31 [ 0.03, 3.03 ]
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
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Analysis 11.1. Comparison 11 Common cold - fever; Delayed versus Immediate Antibiotics, Outcome 1
Fever on Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 11 Common cold - fever; Delayed versus Immediate Antibiotics
Outcome: 1 Fever on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 5/67 6/62 0.75 [ 0.22, 2.60 ]
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
Analysis 11.2. Comparison 11 Common cold - fever; Delayed versus Immediate Antibiotics, Outcome 2
Fever on Day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 11 Common cold - fever; Delayed versus Immediate Antibiotics
Outcome: 2 Fever on Day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 3/67 4/62 0.68 [ 0.15, 3.17 ]
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
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Analysis 11.3. Comparison 11 Common cold - fever; Delayed versus Immediate Antibiotics, Outcome 3
Fever severity on Day 1.
Review: Delayed antibiotics for respiratory infections
Comparison: 11 Common cold - fever; Delayed versus Immediate Antibiotics
Outcome: 3 Fever severity on Day 1
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Arroll 2002a 67 36.74 (0.65) 61 36.87 (0.68) -0.13 [ -0.36, 0.10 ]
-10 -5 0 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
Analysis 11.4. Comparison 11 Common cold - fever; Delayed versus Immediate Antibiotics, Outcome 4
Fever severity on Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 11 Common cold - fever; Delayed versus Immediate Antibiotics
Outcome: 4 Fever severity on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Arroll 2002a 61 36.15 (0.73) 58 36.39 (0.58) -0.24 [ -0.48, 0.00 ]
-10 -5 0 5 10
Favours delayed antibiotics Favours immediate antibiotics
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Analysis 11.5. Comparison 11 Common cold - fever; Delayed versus Immediate Antibiotics, Outcome 5
Fever severity on Day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 11 Common cold - fever; Delayed versus Immediate Antibiotics
Outcome: 5 Fever severity on Day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Arroll 2002a 59 36 (0.77) 60 36.32 (0.58) -0.32 [ -0.57, -0.07 ]
-10 -5 0 5 10
Favours delayed antibiotics Favours Immediate antibiotics
Analysis 12.1. Comparison 12 Common cold - cough; Delayed versus Immediate Antibiotics, Outcome 1
Cough on Day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 12 Common cold - cough; Delayed versus Immediate Antibiotics
Outcome: 1 Cough on Day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 54/67 51/62 0.90 [ 0.37, 2.18 ]
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
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Analysis 12.2. Comparison 12 Common cold - cough; Delayed versus Immediate Antibiotics, Outcome 2
Cough on Day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 12 Common cold - cough; Delayed versus Immediate Antibiotics
Outcome: 2 Cough on Day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 41/61 43/58 0.72 [ 0.32, 1.58 ]
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
Analysis 13.1. Comparison 13 Antibiotic use; Delayed versus Immediate Antibiotics, Outcome 1 Antibiotic
use: immediate versus delayed antibiotics.
Review: Delayed antibiotics for respiratory infections
Comparison: 13 Antibiotic use; Delayed versus Immediate Antibiotics
Outcome: 1 Antibiotic use: immediate versus delayed antibiotics
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Arroll 2002a 32/67 55/67 0.20 [ 0.09, 0.44 ]
Dowell 2001 43/95 92/92 0.00 [ 0.00, 0.07 ]
Little 1997 55/176 210/211 0.00 [ 0.00, 0.02 ]
Little 2001 36/150 132/151 0.05 [ 0.02, 0.08 ]
Little 2005a 39/197 185/193 0.01 [ 0.00, 0.02 ]
Spiro 2006 50/132 116/133 0.09 [ 0.05, 0.17 ]
0.001 0.01 0.1 1 10 100 1000
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Analysis 14.1. Comparison 14 Antibiotic use; Delayed versus No Antibiotics, Outcome 1 Antibiotic use:
delayed versus no antibiotics.
Review: Delayed antibiotics for respiratory infections
Comparison: 14 Antibiotic use; Delayed versus No Antibiotics
Outcome: 1 Antibiotic use: delayed versus no antibiotics
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chao 2008 40/106 13/100 4.06 [ 2.01, 8.19 ]
Little 1997 55/176 23/184 3.18 [ 1.85, 5.46 ]
Little 2005a 39/197 29/182 1.30 [ 0.77, 2.21 ]
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours No antibiotics
Analysis 15.1. Comparison 15 Patient satisfaction; Delayed versus Immediate Antibiotics, Outcome 1
Patient satisfaction: Delayed versus Immediate Antibiotics.
Review: Delayed antibiotics for respiratory infections
Comparison: 15 Patient satisfaction; Delayed versus Immediate Antibiotics
Outcome: 1 Patient satisfaction: Delayed versus Immediate Antibiotics
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Arroll 2002a 64/67 58/62 6.3 % 1.47 [ 0.32, 6.85 ]
Dowell 2001 71/73 75/75 1.6 % 0.19 [ 0.01, 4.01 ]
Little 1997 165/177 202/211 18.1 % 0.61 [ 0.25, 1.49 ]
Little 2001 115/150 123/135 27.8 % 0.32 [ 0.16, 0.65 ]
Little 2005a 147/190 166/194 46.1 % 0.58 [ 0.34, 0.97 ]
Total (95% CI) 657 677 100.0 % 0.52 [ 0.35, 0.76 ]
Total events: 562 (Delayed antibiotics), 624 (Immediate antibiotics)
Heterogeneity: Tau2 = 0.01; Chi2 = 4.28, df = 4 (P = 0.37); I2 =6%
Test for overall effect: Z = 3.31 (P = 0.00092)
0.02 0.1 1 10 50
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Analysis 16.1. Comparison 16 Patient satisfaction; Delayed versus No Antibiotics, Outcome 1 Patient
satisfaction: delayed antibiotics versus no antibiotics.
Review: Delayed antibiotics for respiratory infections
Comparison: 16 Patient satisfaction; Delayed versus No Antibiotics
Outcome: 1 Patient satisfaction: delayed antibiotics versus no antibiotics
Study or subgroup Delayed Antibiotics No Antibiotics Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chao 2008 101/106 91/100 11.1 % 2.00 [ 0.65, 6.18 ]
Little 1997 165/177 166/184 24.5 % 1.49 [ 0.70, 3.19 ]
Little 2005a 147/190 130/181 64.4 % 1.34 [ 0.84, 2.14 ]
Total (95% CI) 473 465 100.0 % 1.44 [ 0.99, 2.10 ]
Total events: 413 (Delayed Antibiotics), 387 (No Antibiotics)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.42, df = 2 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 1.89 (P = 0.058)
0.1 0.2 0.5 1 2 5 10
Favours no antibiotics Favours Delayed antibiotics
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Analysis 17.1. Comparison 17 Adverse events: Delayed versus Immediate Antibiotics, Outcome 1 Vomiting.
Review: Delayed antibiotics for respiratory infections
Comparison: 17 Adverse events: Delayed versus Immediate Antibiotics
Outcome: 1 Vomiting
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
El-Daher 1991 57/118 4/111 25.00 [ 8.65, 72.25 ]
Little 1997 15/179 18/215 1.00 [ 0.49, 2.05 ]
Spiro 2006 15/132 15/133 1.01 [ 0.47, 2.16 ]
0.001 0.01 0.1 1 10 100 1000
Favours Delayed antibiotics Favours Immediate antibiotics
Analysis 17.2. Comparison 17 Adverse events: Delayed versus Immediate Antibiotics, Outcome 2
Diarrhoea.
Review: Delayed antibiotics for respiratory infections
Comparison: 17 Adverse events: Delayed versus Immediate Antibiotics
Outcome: 2 Diarrhoea
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 11/67 12/62 0.82 [ 0.33, 2.02 ]
Little 1997 23/179 23/215 1.23 [ 0.67, 2.28 ]
Little 2001 14/150 25/135 0.45 [ 0.22, 0.91 ]
Spiro 2006 10/132 31/133 0.27 [ 0.13, 0.58 ]
0.1 0.2 0.5 1 2 5 10
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Analysis 17.3. Comparison 17 Adverse events: Delayed versus Immediate Antibiotics, Outcome 3 Rash.
Review: Delayed antibiotics for respiratory infections
Comparison: 17 Adverse events: Delayed versus Immediate Antibiotics
Outcome: 3 Rash
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 1997 11/180 14/215 0.93 [ 0.41, 2.11 ]
Little 2001 8/150 6/135 1.21 [ 0.41, 3.58 ]
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
Analysis 17.4. Comparison 17 Adverse events: Delayed versus Immediate Antibiotics, Outcome 4 Stomach
ache.
Review: Delayed antibiotics for respiratory infections
Comparison: 17 Adverse events: Delayed versus Immediate Antibiotics
Outcome: 4 Stomach ache
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 1997 48/180 66/215 0.82 [ 0.53, 1.27 ]
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
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Analysis 18.1. Comparison 18 Adverse events: Delayed versus No Antibiotics, Outcome 1 Vomiting.
Review: Delayed antibiotics for respiratory infections
Comparison: 18 Adverse events: Delayed versus No Antibiotics
Outcome: 1 Vomiting
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 1997 15/179 22/186 0.68 [ 0.34, 1.36 ]
0.01 0.1 1 10 100
Favours Delayed antibiotics Favours No antibiotics
Analysis 18.2. Comparison 18 Adverse events: Delayed versus No Antibiotics, Outcome 2 Diarrhoea.
Review: Delayed antibiotics for respiratory infections
Comparison: 18 Adverse events: Delayed versus No Antibiotics
Outcome: 2 Diarrhoea
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chao 2008 0/106 0/100 0.0 [ 0.0, 0.0 ]
Little 1997 23/179 16/186 1.57 [ 0.80, 3.07 ]
0.01 0.1 1 10 100
Favours Delayed antibiotics Favours No antibiotics
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Analysis 18.3. Comparison 18 Adverse events: Delayed versus No Antibiotics, Outcome 3 Rash.
Review: Delayed antibiotics for respiratory infections
Comparison: 18 Adverse events: Delayed versus No Antibiotics
Outcome: 3 Rash
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 1997 11/179 21/186 0.51 [ 0.24, 1.10 ]
0.01 0.1 1 10 100
Favours Delayed antibiotics Favours No antibiotics
Analysis 18.4. Comparison 18 Adverse events: Delayed versus No Antibiotics, Outcome 4 Stomach ache.
Review: Delayed antibiotics for respiratory infections
Comparison: 18 Adverse events: Delayed versus No Antibiotics
Outcome: 4 Stomach ache
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 1997 48/179 52/186 0.94 [ 0.60, 1.50 ]
0.01 0.1 1 10 100
Favours Delayed antibiotics Favours No antibiotics
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Analysis 19.1. Comparison 19 Re-consultation rate; Delayed versus Immediate Antibiotics, Outcome 1
Reconsultation rate.
Review: Delayed antibiotics for respiratory infections
Comparison: 19 Re-consultation rate; Delayed versus Immediate Antibiotics
Outcome: 1 Reconsultation rate
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Pichichero 1987 8/55 10/59 45.5 % 0.83 [ 0.30, 2.29 ]
Spiro 2006 13/132 11/133 54.5 % 1.21 [ 0.52, 2.81 ]
Total (95% CI) 187 192 100.0 % 1.04 [ 0.55, 1.98 ]
Total events: 21 (Delayed antibiotics), 21 (Immediate antibiotics)
Heterogeneity: Chi2 = 0.31, df = 1 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.91)
0.1 0.2 0.5 1 2 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
A D D I T I O N A L T A B L E S
Table 1. Summary of outcomes
Study Outcome Favours Result (with 95% CI) Notes
Sore throat
Outcomes in this table are
the result of a comparison
between delayed and im-
mediate antibiotics unless
otherwise specified
Pichichero 1987 Fever severity on Day 3 SMD 0.40 (0.05 to 0.75)
Malaise severity on Day 3 No difference MD 0.20 (-0.11 to 0.51)
Pain severity on Day 3 No difference MD 0.30 (-0.15 to 0.75)
Compliance No difference 100% in both groups
Gerber 1990 Recurrence rate No difference
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Table 1. Summary of outcomes (Continued)
Compliance Delayed antibiotics 88% in immediate group
and 93% in the delayed
group
El Daher 1991 Vomiting Immediate antibiotics OR 25.00 (8.65 to 72.25)
Pain on Day 3 Immediate antibiotics OR 14.51 (7.14 to 29.50)
Malaise on Day 3 Immediate antibiotics OR 16.49 (5.68 to 47.83)
Fever severity on Day 3 Immediate antibiotics SMD 0.58 [0.31, 0.84]
Compliance
Little 1997 Vomiting No difference OR 1.00 (0.49, 2.05)
Diarrhoea No difference OR 1.23 (0.67, 2.28)
Rash No difference OR 0.93 (0.41, 2.11)
Stomach ache No difference OR 0.82 (0.53, 1.27)
Fever (> 37.0 ºC) Immediate antibiotics
Sore throat No difference
Cough No difference
Malaise No difference
Analgesic use No difference
Time off work No difference
AOM
Little 2001 Diarrhoea Delayed antibiotics OR 0.45 (0.22 to 0.91)
Rash No difference OR 1.21 (0.41 to 2.58)
Patients with pain on Day
3
No difference OR 1.93 (0.96 to 3.88)
Patients with pain on Day
7
No difference OR 6.55 (0.33 to 128.35)
Patients with malaise on
Day 3
Immediate antibiotics OR 2.62 (1.44 to 4.76)
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Table 1. Summary of outcomes (Continued)
Malaise severity Day 3 Immediate antibiotics MD 0.43 (0.11 to 0.75)
Malaise severity on Day 7 No difference MD 0.01 (-0.11 to 0.13)
Pain severity on Day 3 Immediate antibiotics MD 0.75 (0.26 to 1.24)
Pain severity on Day 7 No difference MD 0.12 (-0.04 to 0.28)
Paracetamol consumption Immediate antibiotics MD 0.59 (0.25 to 0.93)
Last day of crying Immediate antibiotics MD 0.69 ( 0.31 to 1.07)
Spiro 2006 Fever day 4 to 6 No difference OR 0.88 (0.53 to 1.47)
Vomiting No difference OR 1.01 (0.47 to 2.16)
Diarrhoea Delayed antibiotics OR 0.27 (0.13 to 0.58)
Chao 2008 Fever Day 3 No difference OR 1.45 (0.50 to 4.24)
Pain Day 3 No difference OR 0.64 (0.29 to 1.38)
Cough
Dowell 2001 Clinical outcomes No difference
Little 2005a All clinical outcomes No difference
Common cold
Arroll 2002 Patients with fever on Day
3
No difference OR 0.75 (0.22 to 2.6)
Patients with fever on Day
7
No difference OR 0.68 (0.15 to 3.17)
Patients with diarrhoea No difference OR 0.79 (0.53 to 1.19)
Patients with pain on Day
3
No difference OR 1.47 (0.58 to 3.77)
Patients with pain on Day
7
No difference OR 0.31 (0.03 to 3.03)
Patients with cough on
Day 3
No difference OR 0.90 (0.37 to 2.18)
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Table 1. Summary of outcomes (Continued)
Patients with cough on
Day 7
No difference OR 0.72 (0.32 to 1.58)
Fever severity Day 3 No difference MD -0.24 (-0.48 to 0.00)
Fever severity on Day 7 Delayed antibiotics MD -0.32 (-0.57 to -0.07) Mean temperature for
both < 37 ºC
Antibiotic use
Sore throat
Little 1997 Antibiotic use (none versus
delayed)
No antibiotics (least antibi-
otic use)
OR 3.18 (1.85, 5.46)
Antibiotic use (delayed ver-
sus immediate)
Delayed antibiotics (less
than immediate)
OR 0.00 (0.00, 0.02)
AOM
Little 2001 Antibiotic use Delayed antibiotics OR 0.05 [0.02, 0.08]
Spiro 2006 Antibiotic use Delayed antibiotics OR 0.09 [0.05, 0.17]
Chao 2008 Antibiotic use No antibiotics OR 4.06 (2.01 to 8.19)
Cough
Dowell 2001 Antibiotic use Delayed antibiotics OR 0.00 (0.00, 0.07)
Little 2005 Antibiotic use (none versus
delayed)
No difference OR 1.30 (0.77, 2.21)
Little 2005 Antibiotic use (delayed ver-
sus immediate)
Delayed antibiotics OR 0.01 (0.00, 0.02)
Common Cold
Arroll 2002 Antibiotic use Delayed antibiotics OR 0.20 (0.09, 0.44)
Patient satisfaction
Sore throat
Little 1997 Patient satisfaction (none
versus delayed)
No difference OR 1.49 (0.70, 3.19)
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Table 1. Summary of outcomes (Continued)
Patient satisfaction (de-
layed versus immediate)
No difference OR 0.61 (0.25, 1.49)
AOM
Little 2001 Patient satisfaction (imme-
diate versus delayed)
Immediate antibiotics OR 0.32 (0.16, 0.65)
Chao 2008 Patient satisfaction (de-
layed versus none)
No difference OR 2.00 (0.65 to 6.18)
Cough
Dowell 2001 Patient satisfaction Immediate antibiotics OR 0.19 [0.01, 4.01]
Little 2005 Patient satisfaction (none
versus delayed)
No difference OR 1.34 (0.84 to 2.14)
Little 2005 Patient satisfaction (de-
layed versus immediate)
Immediate antibiotics OR 0.58 (0.34, 0.97)
Common cold
Arroll 2002 Patient satisfaction No difference OR 1.47 (0.32, 6.85)
Secondary outcomes
Sore throat
Pichichero 1987 Re-consultation rate No difference OR 0.83 (0.30 to 2.29)
AOM
Spiro 2006 Reconsultation rate No difference OR 1.21 (0.52 to 2.81)
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A P P E N D I C E S
Appendix 1. Ovid EMBASE search strategy
Ovid EMBASE
1 exp Respiratory Tract Infection/
2 exp Upper Respiratory Tract Infection/
3 (upper respiratory tract infection$ or urti).mp.
4 exp Otitis Media/
5 otitis media.mp.
6 exp Pharyngitis/
7 pharyngitis.mp.
8 exp Tonsillitis/
9 tonsillitis.mp.
10 exp Common Cold/
11 common cold.mp.
12 exp Bronchitis/
13 bronchitis.mp.
14 exp Sinusitis/
15 sinusitis.mp.
16 sore throat$.mp.
17 or/1-16
18 exp Antibiotic Agent/
19 antibiotic$.mp.
20 or/18-19
21 (delay$ adj15 prescri$).mp.
22 and/17,20-21
Appendix 2. ISI Science Citation Index search strategy
ISI Current Contents Connect (Web of Knowledge)
#14 #13 AND #12 AND #9
#13 TS=antibiotic*
#12 #11 OR #10
#11 TS=immediate*
#10 TS=delay*
#9 #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1
#8 TS=sore throat
#7 TS=sinusitis
#6 TS=bronchitis
#5 TS=common cold*
#4 TS=tonsillitis
#3 TS=pharyngitis
#2 TS=otitis media
#1 TS=respiratory tract infection*
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Appendix 3. EBSCO CINAHL search strategy
S15 S10 and S13 and S14
S14 TI delay* N15 prescri* or AB delay* N15 prescri*
S13 S11 or S12
S12 TI antibiotic* or AB antibiotic*
S11 (MH “Antibiotics+”)
S10 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9
S9 TI ( otitis media or pharyngitis or tonsillitis or common cold* or bronchitis or sinusitis or sore throat* ) or AB ( otitis media or
pharyngitis or tonsillitis or common cold* or bronchitis or sinusitis or sore throat* )
S8 (MH “Sinusitis+”)
S7 (MH “Bronchitis+”)
S6 (MH “Common Cold”)
S5 (MH “Tonsillitis+”)
S4 (MH “Pharyngitis”)
S3 (MH “Otitis Media+”)
S2 TI ( upper respiratory tract infection* or urti ) or AB ( upper respiratory tract infection* or urti )
S1 (MH “Respiratory Tract Infections+”)
F E E D B A C K
Feedback: Analysis 15.01 Comparison 15 may have some errors, 9 June 2008
Summary
Feedback: Analysis 15.01 Comparison 15 Patient satisfaction immediate versus delayed antibiotics, Outcome 01 Patient satisfaction:
immediate versus delayed antibiotics may have some errors.
We think that the extracted data has been entered under the wrong headings, i.e. for Little 1997, it reports that 165/177 were satisfied
with delayed antibiotics but the RevMan forest plot has 165/177 under the immediate antibiotics.
Data extracted from one article (Dowell 2001) may have been entered incorrectly, i.e. the percentage has been entered into RevMan
directly rather than as the actual number. In other words, for Dowell 2001, the paper reports 100% (73% very satisfied and 27%
moderately satisfied), whereas the forest plot has reported the 73% as 73/75. This is a double query ? see below for issue of inconsistent
grouping of satisfaction scores.
Suggest that the data extracted for Dowell 2001 should be consistent with the logic used for Arroll 2002 in their results for the same
outcome.
We think that possibly the forest plot analysis should be conducted with the figures below. We have looked at all the original papers.
Arroll 2002a
64/67* Delayed Antibiotics
58/62* Immediate Antibiotics
Dowell 2001
71/73# Delayed Antibiotics
75/75# Immediate Antibiotics
Little 1997
165/177 Delayed Antibiotics
202/211 Immediate Antibiotics
Little 2001
115/150 Delayed Antibiotics
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123/135 Immediate Antibiotics
Little 2005a
147/190 Delayed Antibiotics
166/194 Immediate Antibiotics
Arroll et al noted that for these results, groups responding 1 and 2 have been combined and groups 3 and 4 have been combined
where: 1= very satisfied; 2= moderately satisfied; 3 = slightly satisfied; 4 = not at all satisfied.
Using similar logic as Arroll et al, results for groups responding ?very satisfied? and ?moderately satisfied? have been combined, as have
?not very satisfied? and ?not at all satisfied? to get the figures in the table above for Dowell 2001. (Note: in the review table, the figures
were extracted directly from the ?very satisfied? column only, where they were presented as a percentage without then recalculating
them as a whole figure).
We don’t think these possible errors effect the overall conclusions made by the authors in the review.
Submitter agrees with default conflict of interest statement:
I certify that I have no affiliations with or involvement in any organisation or entity with a financial interest in the subject matter of
my feedback.
Reply
We thank those who have given feedback on this review. We greatly appreciate the work you have done to uncover these errors and
the opportunity you have given us to correct them. We agree with all the feedback you have submitted and have made corrections
to analysis 15 comparison 15.1, analysis 16 comparison 16.1, analysis 13 comparison 13.1 (antibiotic use delayed versus immediate),
analysis 14 comparison 14.1 (antibiotic use delayed versus none) and analysis 3 comparison 3.1 (fever severity on day 3). We have also
added an analysis 17: adverse events delayed versus no antibiotics.
Theses changes have not fundamentally changed the results of the review. However the text and outcome tables have been amended to
reflect changes made.
Geoff Spurling, Chris Del Mar, Liz Dooley
Feedback reply added 25 June 2008
Contributors
Dianne Lowe, Rebecca Ryan
Feedback comment added 16 June 2008
WH A T ’ S N E W
Last assessed as up-to-date: 26 March 2009.
Date Event Description
9 December 2010 Amended Contact details updated.
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H I S T O R Y
Protocol first published: Issue 4, 2003
Review first published: Issue 4, 2004
Date Event Description
5 August 2010 Amended Contact details updated.
27 March 2009 New search has been performed Searches conducted. This 2009 update contains one new study (Chao 2008)
and Feeback on a comment submitted via The Cochrane Library.
16 June 2008 Feedback has been incorporated Feedback comment added.
16 June 2008 Amended Converted to new review format.
21 January 2007 New search has been performed Searches conducted.
9 January 2004 New search has been performed Searches conducted.
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Medical Subject Headings (MeSH)
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plications; ∗drug therapy]
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